德全药品 (871444.OC)

+ 收藏

现金流量表(德全药品)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 317,828,935.28172,476,047.98383,978,488.27182,100,641.74
 收到其他与经营活动有关的现金(元) 15,445,607.069,968,155.334,766,186.602,606,666.72
 经营活动现金流入小计(元) 333,274,542.34182,444,203.31388,744,674.87184,707,308.46
 购买商品、接受劳务支付的现金(元) 82,511,073.4143,810,489.68109,831,110.0154,639,518.42
 支付给职工以及为职工支付的现金(元) 83,035,125.8245,158,600.3577,473,231.8243,526,455.52
 支付的各项税费(元) 40,092,993.6524,702,943.0031,931,232.9010,877,010.37
 支付其他与经营活动有关的现金(元) 93,178,726.2162,562,875.27141,280,993.1269,890,490.45
 经营活动现金流出小计(元) 298,817,919.09176,234,908.30360,516,567.85178,933,474.76
 经营活动产生的现金流量净额(元) 34,456,623.256,209,295.0128,228,107.025,773,833.70
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 28,367.2766,483.19-11,656.03
 收到其他与投资活动有关的现金(元) 25,324.45---
 投资活动现金流入小计(元) 53,691.7266,483.19-11,656.03
 购建固定资产、无形资产和其他长期资产支付的现金(元) 19,799,153.305,556,607.3915,656,503.555,850,252.66
 投资活动现金流出小计(元) 19,799,153.305,556,607.3915,656,503.555,850,252.66
 投资活动产生的现金流量净额(元) -19,745,461.58-5,490,124.20-15,656,503.55-5,838,596.63
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 69,000,000.0070,000,000.0049,900,000.0027,900,000.00
 筹资活动现金流入小计(元) 69,000,000.0070,000,000.0049,900,000.0027,900,000.00
 偿还债务支付的现金(元) 54,000,000.0045,900,000.0051,407,500.0035,407,500.00
 分配股利、利润或偿付利息支付的现金(元) 33,455,861.9832,411,596.6721,603,765.95672,636.99
 支付其他与筹资活动有关的现金(元) 617,834.00193,552.70213,991.54320,154.65
 筹资活动现金流出小计(元) 88,073,695.9878,505,149.3773,225,257.4936,400,291.64
 筹资活动产生的现金流量净额(元) -19,073,695.98-8,505,149.37-23,325,257.49-8,500,291.64
四、汇率变动对现金及现金等价物的影响(元) 45,251.1568,163.65197,881.2497,697.91
五、现金及现金等价物净增加额(元) -4,317,283.16-7,717,814.91-10,555,772.78-8,467,356.66
 加:期初现金及现金等价物余额(元) 38,175,749.8038,175,749.8048,731,522.5848,731,522.58
 期末现金及现金等价物余额(元) 33,858,466.6430,457,934.8938,175,749.8040,264,165.92
补充资料:
 净利润(元) 13,995,582.137,447,253.0728,394,057.7914,069,534.73
 资产减值准备(元) 1,562,642.74-819,052.851,719,995.82-1,632,102.14
 固定资产和投资性房地产折旧(元) 11,761,183.855,866,105.6110,735,926.975,196,925.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 11,761,183.855,866,105.6110,735,926.975,196,925.73
 无形资产摊销(元) 2,491,048.841,177,497.181,606,155.99915,534.71
 长期待摊费用摊销(元) 121,839.35---
 处置固定资产、无形资产和其他长期资产的损失(元) -28,367.27-28,170.17--377.00
 固定资产报废损失(元) 177,665.32163,440.07164,278.2644,774.86
 公允价值变动损失(元) -499,708.67---
 财务费用(元) 1,859,678.69792,873.871,165,874.17519,893.01
 投资损失(元) 535,318.88352,896.84596,287.90209,616.35
 递延所得税(元) 55,491.13227,824.45776,201.08259,625.21
  其中:递延所得税资产减少(元) 123,035.60285,210.66180,733.30259,625.21
 递延所得税负债增加(元) -67,544.47-57,386.21595,467.78-
 存货的减少(元) 5,694,573.52-19,272,411.88-22,122,859.22-8,970,082.39
 经营性应收项目的减少(元) 33,950,215.4539,093,045.19-4,216,798.27-4,442,759.51
 经营性应付项目的增加(元) -36,379,563.20-28,988,460.799,162,609.85-396,749.86
 现金的期末余额(元) 33,858,466.6430,457,934.8938,175,749.8040,264,165.92
 减:现金的期初余额(元) 38,175,749.8038,175,749.8048,731,522.5848,731,522.58
 现金及现金等价物的净增加额(元) -4,317,283.16-7,717,814.91-10,555,772.78-8,467,356.66
公告日期 2024-04-252023-08-162023-04-202022-08-16
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院